Bicara Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 17 Sep 24 | BuyUS$1,260,000 | Deerfield Management Company, L.P. Series C | Company | 70,000 | US$18.00 | |
| 16 Sep 24 | BuyUS$32,994,000 | RA Capital Management, L.P. | Company | 1,833,000 | US$18.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 324,552 | 0.597% |
| Individual Insiders | 851,618 | 1.57% |
| Public Companies | 5,523,897 | 10.2% |
| Institutions | 6,451,234 | 11.9% |
| VC/PE Firms | 16,178,213 | 29.7% |
| General Public | 25,056,411 | 46.1% |
Dilution of Shares: BCAX only recently listed within the past 12 months
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 6,955,993 | US$177.0m | 0% | 2.03% | |||
| 5,523,897 | US$140.5m | 0% | no data | |||
| 3,170,509 | US$80.7m | 0% | no data | |||
| 3,041,286 | US$77.4m | 0% | 1.84% | |||
| 3,010,425 | US$76.6m | 0% | 0.2% | |||
| 2,495,333 | US$63.5m | 0% | no data | |||
| 1,795,174 | US$45.7m | 0% | 0.7% | |||
| 1,115,333 | US$28.4m | 0% | 12.09% | |||
| 1,013,853 | US$25.8m | 0% | 0.01% | |||
| 449,405 | US$11.4m | 0% | no data | |||
| 324,552 | US$8.3m | 0% | no data | |||
| 211,140 | US$5.4m | 0% | no data | |||
| 111,126 | US$2.8m | 0% | no data | |||
| 35,497 | US$903.1k | 0% | no data | |||
| 31,541 | US$802.3k | 0% | 0.87% | |||
| 27,781 | US$706.7k | 0% | no data | |||
| 16,669 | US$424.1k | 0% | no data |